These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35752274)

  • 21. A reporter cell system for the triggering receptor expressed on myeloid cells 2 reveals differential effects of disease-associated variants on receptor signaling and activation by antibodies against the stalk region.
    Ibach M; Mathews M; Linnartz-Gerlach B; Theil S; Kumar S; Feederle R; Brüstle O; Neumann H; Walter J
    Glia; 2021 May; 69(5):1126-1139. PubMed ID: 33314333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TREM2 Variants and Neurodegenerative Diseases: A Systematic Review and Meta-Analysis.
    Zhou SL; Tan CC; Hou XH; Cao XP; Tan L; Yu JT
    J Alzheimers Dis; 2019; 68(3):1171-1184. PubMed ID: 30883352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution and signaling of TREM2/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia.
    Sessa G; Podini P; Mariani M; Meroni A; Spreafico R; Sinigaglia F; Colonna M; Panina P; Meldolesi J
    Eur J Neurosci; 2004 Nov; 20(10):2617-28. PubMed ID: 15548205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lesion-associated microglia and macrophages mediate corralling and react with massive phagocytosis for debris clearance and wound healing after LPS-induced dopaminergic depletion.
    Heman-Bozadas P; Romero C; Martínez-Remedios P; Freitag I; Frías A; Saavedra-López E; Casanova PV; Roig-Martínez M; Cribaro GP; Rovirosa-Hernández MJ; Hernandez-Baltazar D; Barcia C
    J Neuroimmunol; 2022 Jun; 367():577874. PubMed ID: 35490443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TREM2 overexpression attenuates neuroinflammation and protects dopaminergic neurons in experimental models of Parkinson's disease.
    Ren M; Guo Y; Wei X; Yan S; Qin Y; Zhang X; Jiang F; Lou H
    Exp Neurol; 2018 Apr; 302():205-213. PubMed ID: 29407460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications.
    Wilms H; Zecca L; Rosenstiel P; Sievers J; Deuschl G; Lucius R
    Curr Pharm Des; 2007; 13(18):1925-8. PubMed ID: 17584117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microglial TREM2 in amyotrophic lateral sclerosis.
    Xie M; Zhao S; Bosco DB; Nguyen A; Wu LJ
    Dev Neurobiol; 2022 Jan; 82(1):125-137. PubMed ID: 34874625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurodegeneration and inflammation in Parkinson's disease.
    Phani S; Loike JD; Przedborski S
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S207-9. PubMed ID: 22166436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of Toll-like receptors and neuroinflammation in Parkinson's disease.
    Heidari A; Yazdanpanah N; Rezaei N
    J Neuroinflammation; 2022 Jun; 19(1):135. PubMed ID: 35668422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-3473b regulates the expression of TREM2/ULK1 and inhibits autophagy in inflammatory pathogenesis of Parkinson disease.
    Lv Q; Zhong Z; Hu B; Yan S; Yan Y; Zhang J; Shi T; Jiang L; Li W; Huang W
    J Neurochem; 2021 May; 157(3):599-610. PubMed ID: 33448372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.
    Castro-Sánchez S; García-Yagüe ÁJ; López-Royo T; Casarejos M; Lanciego JL; Lastres-Becker I
    Glia; 2018 Aug; 66(8):1752-1762. PubMed ID: 29624735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-let-7a suppresses α-Synuclein-induced microglia inflammation through targeting STAT3 in Parkinson's disease.
    Zhang J; Dongwei Zhou ; Zhang Z; Xinhui Qu ; Kunwang Bao ; Guohui Lu ; Jian Duan
    Biochem Biophys Res Commun; 2019 Nov; 519(4):740-746. PubMed ID: 31547989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular Vesicles as Nanotherapeutics for Parkinson's Disease.
    Leggio L; Paternò G; Vivarelli S; L'Episcopo F; Tirolo C; Raciti G; Pappalardo F; Giachino C; Caniglia S; Serapide MF; Marchetti B; Iraci N
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32948090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TREM2 interacts with TDP-43 and mediates microglial neuroprotection against TDP-43-related neurodegeneration.
    Xie M; Liu YU; Zhao S; Zhang L; Bosco DB; Pang YP; Zhong J; Sheth U; Martens YA; Zhao N; Liu CC; Zhuang Y; Wang L; Dickson DW; Mattson MP; Bu G; Wu LJ
    Nat Neurosci; 2022 Jan; 25(1):26-38. PubMed ID: 34916658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TREM2 Protein Expression Changes Correlate with Alzheimer's Disease Neurodegenerative Pathologies in Post-Mortem Temporal Cortices.
    Lue LF; Schmitz CT; Serrano G; Sue LI; Beach TG; Walker DG
    Brain Pathol; 2015 Jul; 25(4):469-80. PubMed ID: 25186950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microglia-Related Gene Triggering Receptor Expressed in Myeloid Cells 2 (TREM2) Is Upregulated in the Substantia Nigra of Progressive Supranuclear Palsy.
    Sánchez-Ruiz de Gordoa J; Erro ME; Vicuña-Urriza J; Zelaya MV; Tellechea P; Acha B; Zueco S; Urdánoz-Casado A; Roldán M; Blanco-Luquin I; Mendioroz M
    Mov Disord; 2020 May; 35(5):885-890. PubMed ID: 32031293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triggering receptor expressed on myeloid cells-2 expression in the brain is required for maximal phagocytic activity and improved neurological outcomes following experimental stroke.
    Kurisu K; Zheng Z; Kim JY; Shi J; Kanoke A; Liu J; Hsieh CL; Yenari MA
    J Cereb Blood Flow Metab; 2019 Oct; 39(10):1906-1918. PubMed ID: 30523715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistent phagocytic characteristics of microglia in the substantia nigra of long-term Parkinsonian macaques.
    Barcia C; Ros CM; Ros-Bernal F; Gómez A; Annese V; Carrillo-de Sauvage MA; Yuste JE; Campuzano CM; de Pablos V; Fernández-Villalba E; Herrero MT
    J Neuroimmunol; 2013 Aug; 261(1-2):60-6. PubMed ID: 23759319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TREM2 in CNS homeostasis and neurodegenerative disease.
    Painter MM; Atagi Y; Liu CC; Rademakers R; Xu H; Fryer JD; Bu G
    Mol Neurodegener; 2015 Sep; 10():43. PubMed ID: 26337043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.